All-in-one C-arm with FPD "BELLIGER ACE"
Space utilization has been maximized through the all-in-one design, and efficient installation and operation are possible even in a limited treatment environment.
New image processing technology and low-dose technology are applied to provide fast and accurate images.
Pluto 0909X is a new CMOS detector independently developed by iRay Technology (Shanghai) Limited, and the scintillator is selected from iRay deposition Csl technology. With its 98μm pixel pitch, more image details can be seen in clinical applications. The ultra-fast 50fps real-time dynamic imaging function provides more possibilities for the clinical application of C-arm. Ultra-high SNR, And ultra-low image lag performance, lay a good data foundation for 3D image reconstruction. The large imaging size of 213x213mm2 provides a better field of view for doctors.
MediConnector Co., Ltd. has developed an intraocular drug delivery device that can insert micro-implants that continuously release drugs within the eyeball. The product is designed to allow implantation in a minimally invasive manner using 22G needles, which dramatically improves the patient's treatment convenience and quality of life by stably supplying drugs for a long period of time without repeated injection treatment.
The device is certified as a second-class medical device and is establishing a thorough quality management system through ISO 13485 and GMP manufacturing facility certification. In addition, we have secured our own technology by completing the patent application.
BELLUXI is a third-generation liquid filler with polycaprolactone (PCL) as its main ingredient.
BELLUXI is highly biocompatible and safe. Polycaprolactone is absorbed slowly after implantation into the skin, so it has less immediate visible effects than hyaluronic acid fillers, which are second-generation fillers.
However, it has the advantage of strongly promoting collagen production in skin tissues long-term, so the effects last naturally for 2-3 years.
In addition, the liquid formulation promotes uniform distribution when injected into the skin, reducing the discomfort of the procedure while enhancing results.
KIMES Secretariat
Rm. 2001, WTC, 511, Yeongdong-daero,
Gangnam-gu, Seoul, 06164, Rep. of Korea
TEL : +82-2-551-0102
E-mail
kimes@kimes.kr
Join Us with #KIMES
This email has been sent by KIMES Secretariat. It is addressed to individuals and companies who have previously exhibited at or attended exhibitions organized by KIMES Secretariat. If you do not wish to receive any more emails, you canUnsubscribe
